Skip to content

Efficacy Of Shriphalshalatu Yog In Treatment Of Irritable Bowel Syndrome

Study The Effect Of Shriphalshalatu Yog In The Treatment Of Sangrahani (Irritable Bowel Syndrome) - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/063376
Enrollment
35
Registered
2024-02-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Sponsors

Dr Madhura P Chavan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age between 18-60 years of both sexes. 2. Patients having classical signs and symptoms of Sangrahani like Antrakujan, Alasya, Daurbalya, Sadana, Drava, Ghana, Snigdha, Aama, Pichila Mala Pravrutti, Sakativedanam Shakrita, Sashabda Mandvedanayukta Mala Pravritti, Pakshat, Maasat, Dashat Va Nityam Mala Vega Prakop, Diva Prakopo Bhavati Ratrou Shaanti Vrajet. 3. Diagnosis as per Rome Criteria III with active Irritable Bowel Syndrome symptoms as indicated by a score between (75 - 299 on IBS SEVERITY SCORING SYSTEM).

Exclusion criteria

Exclusion criteria: 1. More than 3 years chronicity of Sangrahani. 2. Laboratory or imaging evidence of an alternative explanation of symptoms. 3. Known cases of active PR bleed and GI disease such as Ulcerative colitis, Crohn’s disease, Amoebiasis, Celiac disease. 4. History of Colon Resection, Abdominal Surgery. 5. Uncontrolled systemic diseases like DM I & II, Hypothyroidism, Hyperthyroidism, IHD, etc. other Congenital and Genetic Disorders, Alcoholic patients. 6. Immunocompromised individuals or subjects on immunosuppressive drugs. 7. Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
75% marked improvement in signs and symptoms of Sangrahani.Timepoint: Baseline and 28th day follow up.

Secondary

MeasureTime frame
1. Regression from Moderate to Mild Grade or Mild Grade to Normal Grade in IBS-SEVERITY SCORING SYSTEM Score. 2. Achieving Type 3 or Type 4 from Bristols Stool Scale (Type 3 & 4 being the ideal stools of a healthy individual according to the Bristols Stool Scale). 3. Improvement in Visual Analogue Scale.Timepoint: 7th, 14th, 21th day follow up.

Countries

India

Contacts

Public ContactDr Dattatraya L Shinde

Bharati Vidyapeeth Deemed To Be University College Of Ayurveda Pune

dshinde249@gmail.com9890111954

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026